HER2 Testing for Gastric Cancer in Latin America

被引：0
|
作者：
Bohn, O. L.
Rios, N. P.
Luna, C.
Mena, F.
Sanchez-Sosa, S.
机构：
[1] Metrohlth Med Ctr, Cleveland, OH USA
[2] Christis Muguerza UPAEP Hosp, Puebla, Mexico
[3] Hosp Dr Max Peralta, Cartago, Costa Rica
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
604
引用
收藏
页码：144A / 144A
页数：1
相关论文
共 50 条
  • [31] A national quality assurance system for HER2 testing in gastric cancer: results and experiences
    Edsjo, A.
    Palmqvist, R.
    Wanders, A.
    Olsson, A.
    Elmberger, G.
    Kolaric, A.
    Ignatova, S.
    Wolving, M.
    Bjelkenkrantz, K.
    VIRCHOWS ARCHIV, 2011, 459 : S322 - S322
  • [32] HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
    Josef Rüschoff
    Manfred Dietel
    Gustavo Baretton
    Susanne Arbogast
    Axel Walch
    Geneviéve Monges
    Marie-Pierre Chenard
    Frédérique Penault-Llorca
    Iris Nagelmeier
    Werner Schlake
    H. Höfler
    H. H. Kreipe
    Virchows Archiv, 2010, 457 : 299 - 307
  • [33] Her2 testing of gastric cancer patients in Albania: results from a retrospective study
    Zeneli, S.
    Ikonomi, M.
    Cela, B.
    Alimehmeti, M.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S95 - S95
  • [34] Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer
    Paula Jiménez-Fonseca
    Alberto Carmona-Bayonas
    Maria Luisa Sánchez Lorenzo
    Javier Gallego Plazas
    Ana Custodio
    Raquel Hernández
    Marcelo Garrido
    Teresa García
    Isabel Echavarría
    Juana María Cano
    Alberto Rodríguez Palomo
    Monserrat Mangas
    Ismael Macías Declara
    Avinash Ramchandani
    Laura Visa
    Antonio Viudez
    Elvira Buxó
    Asunción Díaz-Serrano
    Carlos López
    Aitor Azkarate
    Federico Longo
    Eduardo Castañón
    Rodrigo Sánchez Bayona
    Paola Pimentel
    Maria Luisa Limón
    Paula Cerdá
    Renata Álvarez Llosa
    Raquel Serrano
    Maria Pilar Felices Lobera
    María Alsina
    Alicia Hurtado Nuño
    Carlos Gómez-Martin
    Gastric Cancer, 2017, 20 : 465 - 474
  • [35] Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Sanchez Lorenzo, Maria Luisa
    Gallego Plazas, Javier
    Custodio, Ana
    Hernandez, Raquel
    Garrido, Marcelo
    Garcia, Teresa
    Echavarria, Isabel
    Maria Cano, Juana
    Rodriguez Palomo, Alberto
    Mangas, Monserrat
    Macias Declara, Ismael
    Ramchandani, Avinash
    Visa, Laura
    Viudez, Antonio
    Buxo, Elvira
    Diaz-Serrano, Asuncin
    Lopez, Carlos
    Azkarate, Aitor
    Longo, Federico
    Castanon, Eduardo
    Sanchez Bayona, Rodrigo
    Pimentel, Paola
    Luisa Limon, Maria
    Cerda, Paula
    Alvarez Llosa, Renata
    Serrano, Raquel
    Felices Lobera, Maria Pilar
    Alsina, Maria
    Hurtado Nuno, Alicia
    Gomez-Martin, Carlos
    GASTRIC CANCER, 2017, 20 (03) : 465 - 474
  • [36] HER2 positive gastric cancer: Who benefits from HER2 targeted therapy?
    Kolbe, K.
    Haffner, I.
    Schierle, K.
    Maier, D.
    Geier, B.
    Luber, B.
    Kretzschmar, A.
    von Weikersthal, Fischer L.
    Ahlborn, M.
    Riera, J.
    Rau, B.
    Siegler, G.
    Fuxius, S.
    Decker, T.
    Wittekind, C.
    Lordick, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 156 - 157
  • [37] HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
    Gomez-Martin, Carlos
    Garralda, Elena
    Jose Echarri, M.
    Ballesteros, Anabel
    Arcediano, Alberto
    Luis Rodriguez-Peralto, Jose
    Hidalgo, Manuel
    Lopez-Rios, Fernando
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (08) : 751 - 757
  • [38] What are NCI-designated cancer centers using for gastric and esophageal cancer HER2 testing?
    Trosman, Julia R.
    Weldon, Christine B.
    Tsongalis, Gregory J.
    Schink, Julian C.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] HER2 as a therapeutic target in the gastric cancer: is it sufficient?
    Chaturvedi, Rupesh
    Singh, Amar
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2012, 31 (03) : 103 - 105
  • [40] HER2 targeting therapy for advanced gastric cancer
    Shitara, Kohei
    ANNALS OF ONCOLOGY, 2016, 27
12345